Melanoma Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment (Targeted Therapy, Chemotherapy, Radiation Therapy, Biological Therapy), By Class of Drugs ( MEK Inhibitors, Monoclonal Antibodies, BRAF Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region Forecast 2019-2030

Melanoma Treatment Market size was valued at US$ 3.26 billion in 2023 and is expected to reach US$ 7.19 billion by 2030, with a CAGR of 16% from 2024-2030. Melanoma is the more serious type of cancer that develops in cells of the skin called melanocytes that produce melanin. Melanoma not only affects the skin but also affects the eyes and rarely, affects internal organs such as the intestine. The exact cause of melanoma is not clearly known, but the exposure of skin to UV radiation or tanning lumps and beds increases the risk of developing melanoma. Upsurge in the global melanoma prevalence rates and pipeline drugs for the treatment of melanoma are projected to boost the global market at significant rates over the forecast period.

According to the World Health Organization (WHO), there is a continuous increase in the global prevalence of melanoma, and estimated that 132,000 melanoma skin cancers occur every year. Companies in the marketplace are focused on the development of new drug treatments and the identification of different novel targets for the treatment of melanoma. For instance, binimetinib is being developed by Array BioPharma under phase 3 clinical trials for various types of cancers including melanoma. Furthermore, companies also focus on collaborations and acquisitions to develop new drug treatments and expand their portfolio in the market.

Melanoma Treatment Market Key Developments

• In September 2017 Merck Sharp & Dohme launched its blockbuster drug Keytruda in India for the treatment of unresectable or metastatic melanoma.